Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.73 | N/A | +1.23% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.73 | N/A | +1.23% |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management expressed a commitment to strategic initiatives despite not providing specific guidance. They acknowledged challenges in the retail environment.
Management highlighted the importance of maintaining market share amidst competitive pressures.
They noted ongoing investments in product innovation to drive future growth.
Prestige Consumer HE's earnings report showed a small beat on EPS, indicating some operational strength. However, the stock fell by 4.59%, likely due to investor concerns about the lack of revenue data and no guidance for future performance. The market may be reacting to uncertainties in the retail sector and the company's ability to navigate competitive pressures.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SEAGATE TECHNOLOGY H
Feb 4, 2019